PSMD1 and COVID-19: When we analyzed the effect of certain mutations in the RBD region of the S1 protein, individually and combined, on the binding of our sera from patients with COVID-19, we found that only the introduction of a combination of the three mutations N501Y, K417N, and E484K into the RBD protein resulted in significantly reduced IgG and IgA antibody titers.